Beyond AUC: a clinician’s guide to building and trusting prediction models in oncology—a narrative review
Background Prediction models are central to advancing precision oncology, yet many fail to translate into clinical practice due to methodological flaws and inadequate validation. This review provides a practical, clinician-oriented guide to the statistical principles and advanced methods for developing, validating, and interpreting robust prediction models. Methods This narrative review used a targeted literature search of PubMed, Embase, and Web of Science to identify methodological papers, reporting guidelines, and representative oncology prediction model studies, with a focus on literature published between January 1, 2005, and February 28, 2025. Landmark methodological papers published before 2005 were also included when directly relevant. Rather than performing a systematic review or meta-analysis, we synthesized key statistical principles and illustrative examples to guide clinicians and researchers through model development, validation, interpretation, and clinical translation. Findings A multifaceted evaluation encompassing discrimination, calibration, clinical utility, and external validation is essential for prediction models. Over-reliance on discrimination metrics such as the area under the receiver operating characteristic curve (AUC), while neglecting calibration and clinical utility, can lead to misleading conclusions about a model’s value. Rigorous external validation in geographically or temporally distinct cohorts is the most direct test of generalizability, and performance degradation should be interpreted through root-cause analysis rather than treated simply as model failure. Key challenges include managing overfitting, selecting appropriate modeling and validation strategies for different oncology scenarios, addressing special settings such as rare tumors and real-world data, and improving the interpretability of complex “black-box” models. Conclusion Building a trustworthy prediction model requires a combination of advanced computational methods and rigorous statistical principles. To bridge the gap from model development to clinical impact, researchers must prioritize comprehensive validation, transparent reporting, scenario-appropriate modeling decisions, and critical assessment of a model’s real-world utility.